We found that the multi-OMICs driver scores of the latter, including TAPBP, were predominantly in the same range as that of the positive control genes (1.24–2.50) (Supplementary Fig. 2d), reinforcing the cancer driver potential of the experimental gene set relative to known driver genes in melanoma. This evidence concerns the gene TAPBP and cancer.